Ultragenyx Pharmaceutical reported $68.14M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Biocryst Pharmaceuticals BCRX:US $ 38.02M 3.74M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Epizyme EPZM:US $ 24.11M 3.09M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Insmed INSM:US $ 59.97M 3.23M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Kyowa Hakko Kirin 4151:JP 37.74B 4.14B
Macrogenics MGNX:US $ 13.67M 2.58M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Moderna Inc MRNA:US 211M 57M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
Vital Therapies VTL:US $ 4.07M 82K
Xoma XOMA:US $ 5.71M 594K